Global Contraceptives Market Analysis, Drivers, Restraints, Opportunities, Threats, Trends, Applications, and Growth Forecast to 2026

MarketResearch.Biz delivers in-depth insights on the overall contraceptives market in its upcoming report titled, “Global Contraceptives Market Trends, Applications, Analysis, Growth, and Forecast: 2017 to 2026”. The global contraceptives market is estimated to register a CAGR of X.X% in terms of value during forecast period 2017–2026. The report offers in-depth insights, revenue details, and other vital information regarding the global contraceptives market, and the various trends, drivers, restraints, opportunities, and threats in the target market till 2026. The report contains insightful and detailed information regarding the various key players operating in the global market, their financials, supply chain trends, technological innovations, key developments, apart from future strategies, acquisitions & mergers, and market footprint. The global contraceptives market report has been segmented on the basis of product type, end user, and region.

Contraception entails artificial or deliberate techniques to prevent pregnancy as a consequence of sexual intercourse, by interfering with normal process of ovulation, fertilization, and implantation using barriers, drugs, medical devices or surgical techniques. Types of contraceptives such as condoms are also used to prevent potential exposure to infection or sexually transmitted diseases. Contraception methods can be temporary and permanent and are available to men and women. Permanent methods include male sterilization (vasectomy), and female sterilization including tubal occlusion or hysteroscopic sterilization. Temporary methods can be hormonal and non-hormonal. Non-hormonal methods include condoms, diaphragms, withdrawal methods, sponges, cervical caps, and non-hormonal IUDs. Condoms, diaphragms, sponges, and cervical caps are also referred to as barrier contraception methods. Hormonal methods include oral contraceptive pills, contraceptive transdermal patches, vaginal rings, hormonal IUDs, and vaginal implants. Hormonal methods are available only for women. Currently, male hormonal contraceptives are being actively researched.

Contraceptive pills contain synthetic sex hormones, estrogen or progestin or a combination of both, which prevent ovulation in females. Available contraceptive devices include coils, loops, triangles, and Ts, and are made of plastic or metal, which prevent fertilized ovum from implanting in the uterus.

Development of products such as self-administrative contraceptive injections, vaginal rings, non-surgical permanent contraception devices, sub-dermal contraceptive implants, etc., are trending in the global contraceptives market.

Major drivers of growth of the global contraceptives market are rising public awareness in making right decisions about their sexual and reproductive health and family planning, increasing cost of living, technological advancements, increasing development of effective female contraceptive drugs and devices, increasing government and NGO initiatives to promote contraceptives, and rising global prevalence of sexually transmitted infections (STI). In low income countries, rise in adoption of permanent contraceptive practices instead of crucial family planning is trending. However, side effects associated with temporary or permanent contraception and rising prevalence of infertility rates are restraining growth of the market.

Adoption of contraceptives is highest in countries in North America. These include pills, male condoms, IUDs, injectables, implants, and other modern barrier methods. Asia Pacific is expected to be the market with the highest revenue generation potential among other regions in the global contraceptive market over the forecast period. In low-income regions such as Africa, approved self-injection contraceptives have been introduced and revenue from sales of these types of products is expected to be significantly high.

Global contraceptives market is segmented and sub-segmented as follows:

Global contraceptives market segmentation, by product type:

• Drugs

• • Contraceptive pills/ Combined hormonal contraceptives (CHCs)
    • Male contraceptive pills
    • Female contraceptive pills
  • Topical contraceptives
  • Contraceptive injectable
  • Others (contraceptive gels, jellies, and creams)

• Medical devices

• • Male contraceptive devices (Condoms)
  • Female contraceptive devices
    • Female Condoms
    • Intrauterine Devices
      • Hormonal IUCD
      • Copper IUCD
    • Contraceptive Sponges
    • Contraceptive Diaphragms
    • Contraceptive Patches
    • Sub-dermal Contraceptive Implants
    • Non-Surgical Permanent Contraceptive Devices
    • Contraceptive Vaginal Rings

Global contraceptives market segmentation, by end user:

• Hospitals
• Home Care
• Clinics
• Ambulatory Surgical Centers

Global contraceptives market segmentation, by region:

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

• Bayer HealthCare AG
• Medisafe Distribution Inc.
• Teva Pharmaceutical Industries Limited
• Medicines360
• Pace Pharmaceuticals Inc.
• Actavis Inc.
• Church & Dwight Co. Inc.
•  CooperSurgical Inc.
•  Mayer Laboratories Inc.
• Merck & Co. Inc.
• Reckitt Benckiser Groups plc
• Pfizer Inc.